Diethylcarbamazine (50mg) + Chlorpheniramine (1.25mg)
Unicarbazan 50 mg/1.25 mg Tablet is used in the treatment of parasitic infections.
10 tablets in 1 strip
Torrent Pharmaceuticals Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Unicarbazan 50 mg/1.25 mg Tablet is to be taken with food.
Unicarbazan 50 mg/1.25 mg Tablet is a combination of two medicines: Diethylcarbamazine and Chlorpheniramine Maleate which treat parasitic infections. Diethylcarbamazine is an antiparasitic which works by decreasing the muscular activity and causing paralysis of the parasites (worms). Chlorpheniramine Maleate is an antiallergic which decreases the raised eosinophil count (white blood cells) and controls allergic symptoms like cough and breathlessness.
Related Warnings
Unicarbazan 50 mg/1.25 mg Tablet may cause excessive drowsiness and calmness with alcohol.
Unknown. Human and animal studies are not available. Please consult your doctor.
No information is available on the use of Unicarbazan 50 mg/1.25 mg Tablet during lactation. Please consult your doctor.
Unicarbazan 50 mg/1.25 mg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Unicarbazan 50 mg/1.25 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Unicarbazan 50 mg/1.25 mg Tablet may not be needed in these patients. Please consult your doctor.
Use of Unicarbazan 50 mg/1.25 mg Tablet may cause excessive sleepiness in patients with end stage kidney disease.
There is limited information available on the use of Unicarbazan 50 mg/1.25 mg Tablet in patients with liver disease. Please consult your doctor.
